Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GSK3B: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Glycogen Synthase Kinase 3 Beta (GSK3B) is a serine/threonine kinase central to tau phosphorylation, Wnt signaling, glycogen metabolism, and neuroinflammation. GSK3B is the primary kinase responsible for hyperphosphorylation of tau at disease-relevant epitopes (AT8, PHF-1), driving neurofibrillary tangle formation in Alzheimer's disease. GSK3B also promotes amyloid-beta production by enhancing gamma-secretase activity and BACE1 expression. In the Wnt pathway, GSK3B phosphorylates beta-catenin for degradation; Wnt signaling inhibits GSK3B, promoting cell survival. Lithium, a GSK3B inhibitor, reduces tau phosphorylation and has shown neuroprotective effects in preclinical models. Selective GSK3B inhibitors are in clinical development for AD and tauopathies.
| Gene Symbol | GSK3B |
| Full Name | Glycogen Synthase Kinase 3 Beta |
| Aliases | GSK-3β, TPKII, Tau tubulin kinase (TTBK) |
| Chromosome | 3q13.33 |
| Protein Type | Serine/Threonine Kinase |
| Function | is a constitutively active serine/threonine kinase encoded by the GSK3B gene that plays central and multifaceted roles in cellular physiology[@woodgett1990]. |
| Primary Expression | Brain (highest), liver, muscle, kidney |
| Molecular Weight | ~47 kDa |
| Amino Acids | 420 aa |
| Exons | 12 |
| Pathways | Akt, Cholesterol, Mapk, Microrna, Nf-Kb |
| UniProt ID | P49841 |
| NCBI Gene ID | 2932 |
| OMIM | 605004 |
| GeneCards | GSK3B |
| Human Protein Atlas | GSK3B |
| Associated Diseases | ALS, ALZHEIMER'S DISEASE, APOPTOSIS, Aging, Alzheimer |
| Known Drugs/Compounds | RAPAMYCIN, Tideglusib, Ficus deltoidea, Sulforaphane, Vitamin B1, Vitamin B2 |
| Interactions | AKT, PTEN, MTOR, MAP1LC3B, LC3, ERN1 |
| KG Connections | 1104 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
GSK3B["GSK3B"] -->|"activates"| apoptosis["apoptosis"]
GSK3B["GSK3B"] -->|"associated"| Cancer["Cancer"]
GSK3B["GSK3B"] -->|"associated"| Carcinoma["Carcinoma"]
GSK3B["GSK3B"] -->|"activates"| Tumor["Tumor"]
GSK3B["GSK3B"] -->|"activates"| Als["Als"]
GSK3B["GSK3B"] -->|"activates"| Alzheimer["Alzheimer"]
oxidative_stress["oxidative stress"] -->|"contributes to"| GSK3B["GSK3B"]
PRKCD["PRKCD"] -->|"associated"| GSK3B["GSK3B"]
TCF4["TCF4"] -->|"associated"| GSK3B["GSK3B"]
MYC["MYC"] -->|"associated"| GSK3B["GSK3B"]
style GSK3B fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| ds-83b31ef18d49 | provides_data_for | dataset | 1.00 |
| Tau Hyperphosphorylation | involved_in | process | 0.95 |
| TAU | modulates | protein | 0.90 |
| Neuronal Development | regulates | process | 0.90 |
| Microtubule Organization | regulates | process | 0.90 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.90 |
| Wnt signaling | participates_in | pathway | 0.90 |
| ALZHEIMER'S DISEASE | contributes_to | disease | 0.88 |
| FYN | phosphorylates | protein | 0.85 |
| PRO-APOPTOTIC FACTORS | activates | protein | 0.85 |
| TAU PROTEIN TANGLE FORMATION | regulates | biological_process | 0.85 |
| AMYLOID BETA ACCUMULATION | regulates | biological_process | 0.85 |
| PGC1A | regulates | gene | 0.85 |
| Neurodevelopmental Diseases | risk_factor_for | disease | 0.85 |
| Axon Regeneration | suppresses | process | 0.85 |
| Apoptosis | upregulates | process | 0.85 |
| APOPTOSIS | promotes | process | 0.85 |
| Hyperthyroidism | downregulates | disease | 0.85 |
| Tau Phosphorylation | mediates | process | 0.85 |
| Neurodegenerative Diseases | risk_factor_for | disease | 0.85 |
| OPTN | phosphorylates | gene | 0.83 |
| Glucose Uptake | regulates | process | 0.80 |
| Tau hyperphosphorylation | mediates | process | 0.80 |
| CHEMOBRAIN | implicated_in | disease | 0.80 |
| apoptosis | activates | phenotype | 0.80 |
| Tau Phosphorylation | upregulates | process | 0.80 |
| MAPK signaling | participates_in | pathway | 0.80 |
| WNT | inhibits | pathway | 0.80 |
| Neuroinflammation | promotes | process | 0.80 |
| Apoptosis | promotes | process | 0.80 |
| DEPRESSION | implicated_in | disease | 0.80 |
| BDNF | regulates | protein | 0.75 |
| Als | activates | disease | 0.75 |
| Cancer | regulates | disease | 0.75 |
| Als | regulates | disease | 0.75 |
| AKT | regulates | gene | 0.70 |
| AKT | activates | gene | 0.70 |
| neural stem cells | regulates | cell_type | 0.70 |
| TGFB1 | associated_with | gene | 0.65 |
| TFEB | co_discussed | gene | 0.65 |
| VCP | co_discussed | gene | 0.65 |
| PI3K | phosphorylates | gene | 0.65 |
| neurodegeneration | co_discussed | concept | 0.65 |
| IL6 | co_discussed | gene | 0.65 |
| TNF | co_discussed | gene | 0.65 |
| PINK1 | co_discussed | gene | 0.65 |
| AKT | inhibits | gene | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Carcinoma | associated_with | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ds-83b31ef18d49 | data_in | dataset | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.98 |
| SB216763 | inhibits | drug | 0.95 |
| AKT | inhibits | protein | 0.90 |
| Tideglusib | inhibits | drug | 0.90 |
| Vitamin B1 | inhibits | drug | 0.90 |
| Vitamin B2 | inhibits | drug | 0.90 |
| Vitamin B3 | inhibits | drug | 0.90 |
| AKT1 | inhibits | protein | 0.90 |
| Thermal Adaptation | upregulates | process | 0.90 |
| AKT | phosphorylates | entity | 0.85 |
| AKT1 | phosphorylates | protein | 0.85 |
| Sulforaphane | activates | compound | 0.85 |
| Thermal adaptation | upregulates | process | 0.85 |
| Doxorubicin | upregulates | drug | 0.85 |
| Hyperthyroidism | downregulates | disease | 0.85 |
| TAU | associated_with | gene | 0.82 |
| PRKCD | associated_with | gene | 0.80 |
| WIF1 | regulates | protein | 0.80 |
| MET | regulates | protein | 0.80 |
| Ficus deltoidea | modulates | compound | 0.80 |
| Testosterone | upregulates | compound | 0.80 |
| MTOR | phosphorylates | gene | 0.80 |
| OLEA | regulates | compound | 0.80 |
| ANTHOCYANINS | inhibits | compound | 0.80 |
| oxidative stress | contributes_to | phenotype | 0.80 |
| LITHIUM | inhibits | drug | 0.80 |
| PI3K | regulates | gene | 0.70 |
| CANCER | regulates | gene | 0.70 |
| MAPT | phosphorylated_by | gene | 0.70 |
| CASP3 | co_discussed | gene | 0.65 |
| BCL2 | co_discussed | gene | 0.65 |
| ATP13A2 | co_discussed | gene | 0.65 |
| APOPTOSIS | targets | phenotype | 0.65 |
| TCF4 | associated_with | gene | 0.60 |
| MYC | associated_with | gene | 0.60 |
| LC3 | associated_with | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| CTNNB1 | associated_with | gene | 0.60 |
| AXIN2 | associated_with | gene | 0.60 |
| GAPDH | associated_with | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| RAB7A | associated_with | gene | 0.60 |
| LAMP1 | associated_with | gene | 0.60 |
| P62 | activates | gene | 0.60 |
| CDK4 | associated_with | gene | 0.60 |
| ESR1 | associated_with | gene | 0.60 |
| CHEK1 | associated_with | gene | 0.60 |
| PIK3CA | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-03 | 17 hypotheses Top: 0.662
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||